×

A simple model of HIV epidemic in Italy: the role of the antiretroviral treatment. (English) Zbl 1373.92077

Summary: In the present paper we propose a simple time-varying ODE model to describe the evolution of HIV epidemic in Italy. The model considers a single population of susceptibles, without distinction of high-risk groups within the general population, and accounts for the presence of immigration and emigration, modelling their effects on both the general demography and the dynamics of the infected subpopulations. To represent the intra-host disease progression, the untreated infected population is distributed over four compartments in cascade according to the CD4 counts. A further compartment is added to represent infected people under antiretroviral therapy. The per capita exit rate from treatment, due to voluntary interruption or failure of therapy, is assumed variable with time. The values of the model parameters not reported in the literature are assessed by fitting available epidemiological data over the decade \(2003 \div 2012\). Predictions until year 2025 are computed, enlightening the impact on the public health of the early initiation of the antiretroviral therapy. The benefits of this change in the treatment eligibility consist in reducing the HIV incidence rate, the rate of new AIDS cases, and the rate of death from AIDS. Analytical results about properties of the model in its time-invariant form are provided, in particular the global stability of the equilibrium points is established either in the absence and in the presence of infected among immigrants.

MSC:

92C60 Medical epidemiology
34D05 Asymptotic properties of solutions to ordinary differential equations
92D30 Epidemiology
Full Text: DOI

References:

[1] M. Arcà, The epidemic dynamics of HIV-1 in Italy: Modelling the interaction between intravenous drug users and heterosexual population,, Stat Med, 11, 1657 (1992)
[2] S. M. Blower, A tale of two futures: HIV and antiretroviral therapy in San Francisco,, Science, 287, 650 (2000) · doi:10.1126/science.287.5453.650
[3] C. Bonifazi, The italian transition from emigration to immigration country,, IRPPS Working Papers, 24, 2 (2009)
[4] L. Camoni, Aggiornamento delle nuove diagnosi di infezione da HIV e dei casi di AIDS in Italia al 31 dicembre 2012,, Notiziario Istituto Superiore di Sanità, 26, 3 (2013)
[5] L. Camoni, Aggiornamento delle nuove diagnosi di infezione da HIV e dei casi di AIDS in Italia al 31 dicembre 2013,, Notiziario Istituto Superiore di Sanità, 27, 3 (2014)
[6] L. Camoni, Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy,, AIDS Res Hum Retrov, 31, 282 (2015) · doi:10.1089/aid.2014.0154
[7] L. Camoni, Estimates of the number of people living with HIV in Italy,, Biomed Res Int, 2014 (2014) · doi:10.1155/2014/209619
[8] N. Crepaz, Highly active antiretroviral therapy and sexual risk behavior: A meta-analytic review,, JAMA-J Am Med Assoc, 292, 224 (2004) · doi:10.1001/jama.292.2.224
[9] O. Diekmann, On the definition and the computation of the basic reproduction ratio \(R_0\) in models for infectious diseases in heterogeneous populations,, J Math Biol, 28, 365 (1990) · Zbl 0726.92018 · doi:10.1007/BF00178324
[10] D. Donnell, Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis,, Lancet, 375, 2092 (2010) · doi:10.1016/S0140-6736(10)60705-2
[11] J. Eaton, Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models,, Lancet Glob Health, 2 (2014) · doi:10.1016/S2214-109X(13)70172-4
[12] M. Franzetti, Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: A single-institution retrospective study before and after the introduction of HAART,, J Acquir Immune Defic Syndr, 62, 414 (2013) · doi:10.1097/QAI.0b013e318282a189
[13] M. Franzetti, Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy,, BMC Infect Dis, 14 (2014) · doi:10.1186/1471-2334-14-398
[14] R. Granich, Highly active antiretroviral treatment for the prevention of HIV transmission,, J Int AIDS Soc, 13 (2010)
[15] R. M. Granich, Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model,, Lancet, 373, 48 (2009) · doi:10.1016/S0140-6736(08)61697-9
[16] H. Guo, Impacts of migration and immigration on disease transmission dynamics in heterogeneous populations,, Discret Contin Dyn S - Series B, 17, 2413 (2012) · Zbl 1252.92050 · doi:10.3934/dcdsb.2012.17.2413
[17] H. Guo, Global stability of the endemic equilibrium of multigroup SIR epidemic models,, Canad Appl Math Quart, 14, 259 (2006) · Zbl 1148.34039
[18] H. Guo, Global dynamics of a general class of multistage models for infectious diseases,, SIAM J Appl Math, 72, 261 (2012) · Zbl 1244.34075 · doi:10.1137/110827028
[19] M. Iannelli, The HIV/AIDS epidemics among drug injectors: A study of contact structure through a mathematical model,, Math Biosci, 139, 25 (1997) · Zbl 0893.92025 · doi:10.1016/S0025-5564(96)00137-X
[20] S. C. Kalichman, HIV treatment beliefs and sexual transmission risk behaviors among HIV positive men and women,, J Behav Med, 29, 401 (2006) · doi:10.1007/s10865-006-9066-3
[21] M. Kretzschmar, Prospects of elimination of HIV with test-and-treat strategy,, Proc Natl Acad Sci USA, 110, 15538 (2013) · Zbl 1292.92010 · doi:10.1073/pnas.1301801110
[22] J. R. Lingappa, Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk,, PLoS One, 5 (2010) · doi:10.1371/journal.pone.0012598
[23] P. M. Luz, Long-term CD4+ cell count in response to combination antiretroviral therapy,, PLoS One, 9 (2014) · doi:10.1371/journal.pone.0093039
[24] K. A. Lythgoe, Is HIV short-sighted? Insights from a multistrain nested model,, Evolution, 67, 2769 (2013) · doi:10.1111/evo.12166
[25] R. Manfredi, HIV disease among immigrants coming to Italy from outside of the European Union: A case-control study of epidemiological and clinical features,, Epidemiol Infect, 127, 527 (2001) · doi:10.1017/S0950268801006227
[26] R. May, Transmission dynamics of HIV infection,, Nature, 326, 137 (1987) · doi:10.1038/326137a0
[27] V. Miller, The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load,, AIDS, 14, 2129 (2000) · doi:10.1097/00002030-200009290-00009
[28] F. Nyabadza, Modelling the HIV/AIDS epidemic trends in South Africa: Insights from a simple mathematical model,, Nonlinear Anal Real World Appl, 12, 2091 (2011) · Zbl 1215.92055 · doi:10.1016/j.nonrwa.2010.12.024
[29] P. Paci, Timely HAART initiation may pave the way for a better viral control,, BMC Infect Dis, 11 (2011) · doi:10.1186/1471-2334-11-56
[30] M. Parczewski, Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from poland differs by transmission category and subtype,, J Antimicrob Chemother, 70, 233 (2015) · doi:10.1093/jac/dku372
[31] V. Patruno, <em>Intercensal Population Estimates. Demographic Balance</em>,, National Institute of Statistics of Italy (ISTAT)
[32] T. C. Quinn, Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group,, N Engl J Med, 343, 921 (2000)
[33] A. S. Rao, HIV/AIDS epidemic in India and predicting the impact of the national response: mathematical modeling and analyis,, Math Biosci Eng, 6, 779 (2009) · Zbl 1178.92048 · doi:10.3934/mbe.2009.6.779
[34] R. J. Smith, Evolutionary dynamics of complex networks of HIV drug-resistant strains: The case of San Francisco,, Science, 327, 697 (2010) · doi:10.1126/science.1180556
[35] T. Sterling, HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy,, AIDS, 15, 2251 (2001)
[36] B. Taiwo, Novel antiretroviral combinations in treatment-experienced patients with HIV infection: Rationale and results,, Drugs, 70, 1629 (2010) · doi:10.2165/11538020-000000000-00000
[37] The INSIGHT START Study Group, Initiation of antiretroviral therapy in early asymptomatic HIV infection,, N Engl J Med, 373, 795 (2015)
[38] P. van den Driessche, Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission,, Math Biosci, 180, 29 (2002) · Zbl 1015.92036 · doi:10.1016/S0025-5564(02)00108-6
[39] J. Vercauteren, Transmission of drug-resistant HIV-1 is stabilizing in europe,, J Infect Dis, 200, 1503 (2009) · doi:10.1086/644505
[40] R. Weber, Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study,, HIV Med, 14, 195 (2013) · doi:10.1111/j.1468-1293.2012.01051.x
[41] When To Start Consortium, Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: A collaborative analysis of 18 HIV cohort studies,, Lancet, 373, 1352 (2009)
[42] WHO Guidelines Approved by the Guidelines Review Committee, <em>Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV</em>,, World Health Organization (2015)
[43] D. P. Wilson, Relation between HIV viral load and infectiousness: A model-based analysis,, Lancet, 372, 314 (2008) · doi:10.1016/S0140-6736(08)61115-0
[44] T. Zhang, Study on a HIV/AIDS model with application to Yunnan province, China,, Appl Math Model, 35, 4379 (2011) · Zbl 1225.92051 · doi:10.1016/j.apm.2011.03.004
[45] M. Zwahlen, <em>Progression and Mortality of Untreated HIV-positive Individuals Living in Resource-Limited Settings: Update of Literature Review and Evidence Synthesis,</em>, Report to UNAIDS obligation no HQ/05/422204.
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. In some cases that data have been complemented/enhanced by data from zbMATH Open. This attempts to reflect the references listed in the original paper as accurately as possible without claiming completeness or a perfect matching.